Compass Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Buy
+775
New +$265K 0.05% 157
2025
Q4
Sell
-775
Closed -$219K 79
2025
Q3
$219K Hold
775
0.05% 145
2025
Q2
$216K Sell
775
-49
-6% -$13.9K 0.05% 147
2025
Q1
$257K Hold
824
0.07% 136
2024
Q4
$215K Hold
824
0.05% 148
2024
Q3
$266K Hold
824
0.06% 145
2024
Q2
$257K Hold
824
0.06% 142
2024
Q1
$234K Hold
824
0.06% 149
2023
Q4
$237K Hold
824
0.07% 144
2023
Q3
$221K Hold
824
0.07% 149
2023
Q2
$183K Hold
824
0.06% 156
2023
Q1
$199K Hold
824
0.06% 155
2022
Q4
$216K Buy
+824
New +$221K 0.07% 150

Other funds holding AMGN

Compass Wealth Management's AMGN Position: Q2 2026 in Review

Compass Wealth Management opened a new position in Amgen (AMGN) in Q2 2026: 775 shares worth $281K. The stake represents 0.05% of the portfolio and ranks #157 among its holdings. This is a return to the name: Compass Wealth Management previously reported a position in AMGN as recently as Q3 2025.

Compass Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Compass Wealth Management held 775 shares of Amgen worth $281K as of Q2 2026.
  • Amgen was a new Compass Wealth Management position in Q2 2026.
  • Amgen made up 0.05% of Compass Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Compass Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Compass Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.